On May 28, 2020 Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel products for serious rare and ultra-rare genetic diseases, reported that it will hold virtual presentations at the following upcoming investor conferences (Press release, Ultragenyx Pharmaceutical, MAY 28, 2020, View Source [SID1234558609]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Shalini Sharp, the company’s Chief Financial Officer, will hold a virtual presentation at the Jefferies Healthcare Conference on Wednesday, June 3, 2020 at 2 PM ET.
Emil D. Kakkis, M.D., Ph.D., the company’s Chief Executive Officer and President, will hold a virtual presentation at the Goldman Sachs 41ST Annual Global Healthcare Conference on Tuesday, June 9, 2020 at 3:50 PM ET.
The live and archived webcast of these presentations will be accessible from the company’s website at View Source Replays of the webcasts will be available for 90 days.